Summit Therapeutics Inc.

Q3 2025 13F Holders

Symbol
SMMT
CUSIP
86627T108
Type
Equity
Class
COM
Num filings
259
Total reported value, excl. options
$2.13 B
Manager Report Date Value ($000) Shares Option Type